South Shore Rehab Hires Dr. Aleem Ali MD As Their New Medical Director

NEXT STORY
Strongbridge Biopharma plc Announces Publication of Diabetes Subgroup Analysis from Phase 3 SONICS Study of RECORLEV® (levoketoconazole) for the Treatment of Endogenous Cushing’s Syndrome in Frontiers in Endocrinology
PREV STORY
IBA’s Proteus®ONE selected by Advocate Radiation Oncology for new proton therapy center in Florida
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

South Shore Rehab Hires Dr. Aleem Ali MD As Their New Medical Director

NEXT STORY
Strongbridge Biopharma plc Announces Publication of Diabetes Subgroup Analysis from Phase 3 SONICS Study of RECORLEV® (levoketoconazole) for the Treatment of Endogenous Cushing’s Syndrome in Frontiers in Endocrinology
PREV STORY
IBA’s Proteus®ONE selected by Advocate Radiation Oncology for new proton therapy center in Florida
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Trillium Therapeutics Reports First Quarter 2018 Financial and Operating Results

Focusing TTI-621 clinical development on T-cell lymphomaTTI-621 received Orphan Drug Designation for the treatment ...

author_avatar
NASDAQ Market News

Global Immunoassay Markets to 2025 – Growing Adoption of Immunoassay-based POC Diagnostics

author_avatar
NASDAQ Market News

NEOVACS STRENGTHENS INTELLECTUAL PROPERTY POSITION IN EUROPE AND JAPAN

PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS STRENGTHENS INTELLECTUAL PROPERTY POSITION  IN ...

author_avatar
NASDAQ Market News